A shadow market for unlicensed slimming medications is propelled by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.
Experimental Treatment Gaining Popularity Online
The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its supposed weight-reducing properties. Followers are urged to message these profiles directly for supplier links, while also obtaining promotional offers.
Active Trade on Messaging Platforms
Additionally, a flourishing trade exists on Telegram, where communities with numerous of members share comparison photos, administration instructions and assertions of next-day British shipping. Sellers market the substance there before redirecting buyers to WhatsApp for transactions.
Learning About The Experimental Drug
This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.
Healthcare Professionals Express Worries
However, physicians and chemists have warned that the sale of what is still an unlicensed drug in the UK is a cause for concern and could result in users administering substances of unknown origin.
Some professionals said the popularity for the experimental drug could be linked to the rising cost of licensed weight loss products such as Mounjaro.
Regulatory Position and Implementation
Marketing the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unlicensed drug that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.
Some content creators attempt to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still breach pharmaceutical, advertising, and consumer regulations, risking fines, prosecution or prison.
Platform Response and Material Removal
According to TikTok, the service has taken down violative content and prohibited related hashtags and search suggestions. The organization stated it was committed to keeping the service safe and investing in enhancing compliance measures.
Digital Trading Activities
Investigations also found groups with up to 9,000 participants marketing the experimental drug using the platform's built-in discovery tool, which functions like a public directory. Entering “retatrutide” immediately brings up channels with thousands of users, populated with photos of weight loss, glowing testimonials and detailed instructions for preparing or administering at residence.
After minutes of entering one community, a vendor shared contact information, where most transactions occur. The seller sent an instruction manual and guaranteed shipping within two days. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None asked about weight, medical conditions or previous experience.
Product Information and Costs
Inside these communities, messages show black plastic packages with Royal Mail stickers, stating to include new batches. One message read: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at home with purified liquid, or ready-to-use injectors usually sold at £160 for 20mg. When asked how much time a pen should last, sellers give conflicting responses varying between a several days to “depends on your body”.
Service Oversight and Security Measures
A representative for the messaging service said it actively moderated dangerous material on its platform including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are injecting materials they cannot confirm. Although the science behind this drug is valid, these online versions may not include what they claim,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to recent cost increases for approved weight-loss drugs such as Mounjaro. “With costs increasing, individuals are turning to social media. But counterfeit injections are highly dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was sterile,” she explained.
Her team has already seen patients injured by self-injection from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or communication platforms is taking chances with your health,” stated the doctor. “These materials could be contaminated or improperly measured.”
Manufacturer Statement
A representative from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or authorized by any government authority globally. “Consequently at this time no one can market [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company experimental substance not yet authorized … may subject patients to potentially serious health risks”.
